The Emory Clinical Translational Research Laboratory (ECTRL) Home Page

Services -

  • Ultra Performance Liquid Chromatography Electrospray Tandem Mass Spectrometry method development
  • Ultra Performance Liquid Chromatography Electrospray Tandem Mass Spectrometry sample analysis
  • Gas Chromatography method development
  • Gas Chromatography sample analysis
  • High Performance Liquid Chromatography method development
  • High Performance Liquid Chromatography sample analysis
  • Microarray gene analysis
  • DNA/RNA isolation and analysis
  • Clinical specimen procurement
  • Stability testing
  • Clinical trials
  • Immunoassay method development
  • Immunoassay sample analysis
  • Method comparison

Description of Services -

  • Method Development –

    ECTRL specializes in the planning, development, and analysis of customized routine and special methods of interest to its customers. Ultra performance liquid chromatography-Electrospray Tandem Mass Spectrometry, High-Performance Liquid Chromatography-UV/electrochemical detection, ELISA, radio-immunoassay, coagulation based assays, and gene- expression analysis systems are some of the methods employed by ECTRL.

  • Sample Analysis –

    ECTRL offers sample analysis using various commercial and customized methodologies of interest to its customers. These methods include, but are not limited to, Liquid Chromatography Electrospray Tandem Mass Spectrometry, Gas Chromatography, High Performance Liquid Chromatography, Microarray gene analysis, and Immunoassay. ECTRL offers procurement and testing of human and non-human samples (see Clinical Specimens) if needed.

  • Stability Testing –

    ECTRL offers this testing in line with published FDA procedures including pyrogen, sterility, and package stability testing.

  • Clinical Specimen Procurement –

    ECTRL offers procurement and testing on residual clinical patient specimens banked from Emory University and its affiliated Hospital’s. The patient population seen in our geographical area presents useful opportunities for translational research on residual specimens procured from the clinical laboratory. Specimens include human and non-human serum, plasma, urine, and cerebral spinal fluid.

  • DNA/RNA Isolation and Analysis –

    ECTRL offers its customers isolation of DNA and RNA from various matrices, including but not limited to, cell culture, human tissue, and plasma. Customized isolation methods are designed to meet the needs of the customer’s downstream applications. DNA and RNA is quantitated and analyzed for integrity using Nanodrop and Agilent RNA Bioanalyzer technology.

  • Clinical Method Validation –

    ECTRL offers to complete validation of clinical methodologies in compliance with mandated FDA procedures.

  • Clinical Trials –

    ECTRL offers complete clinical trials management from patient enrollment to completion of all laboratory analyses and document preparation.

  • Consultation –

    The ECTRL Director’s offer extensive consultation services. Dr. Ritchie and Dr. Molinaro have experience in FDA approval processes, clinical trial testing, clinical quality control, clinical quality assurance, and clinical laboratory regulations and requirements.